Telavancin

Red

Brand Name(s):Vibativ

Indication:Nosocomial pneumonia

Rationale:1,2

Considered:Aug-14

Review Date:Feb-20

Comments:
Drug Safety Update
Recommendations for use and important risks (nephrotoxicity, QTc prolongation, reproductive toxicity and off-label use) – Sent by Clinigen, full ifo at:
https://assets.digital.cabinet-office.gov.uk/media/54db0ddd40f0b670f4000007/Vibativ_DHPC_sent_12_Nov_2014.pdf
Nov 2014